Mark J. Levin, Director at MILLENNIUM PHARMACEUTICALS INC (MLNM), sold 6,800 shares at $13.06 ($90K) on 2007-11-07, disclosed to the SEC on 2007-11-08.
Scheduled sale ($90k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.88 | 200 | $3K | 2.9% |
| 2 | $12.90 | 200 | $3K | 2.9% |
| 3 | $12.92 | 200 | $3K | 2.9% |
| 4 | $13.02 | 100 | $1K | 1.5% |
| 5 | $13.04 | 300 | $4K | 4.4% |
| 6 | $13.05 | 100 |
| $1K |
| 1.5% |
| 7 | $13.06 | 300 | $4K | 4.4% |
| 8 | $13.07 | 300 | $4K | 4.4% |
| 9 | $13.08 | 200 | $3K | 2.9% |
| 10 | $13.10 | 200 | $3K | 2.9% |
| 11 | $13.16 | 400 | $5K | 5.9% |
| 12 | $13.17 | 400 | $5K | 5.9% |
| 13 | $13.19 | 600 | $8K | 8.8% |
| 14 | $13.20 | 500 | $7K | 7.4% |
| 15 | $13.22 | 400 | $5K | 5.9% |
| 16 | $13.24 | 200 | $3K | 3.0% |
| 17 | $13.25 | 300 | $4K | 4.4% |
| 18 | $13.27 | 200 | $3K | 3.0% |
| 19 | $13.28 | 100 | $1K | 1.5% |
| 20 | $13.32 | 300 | $4K | 4.5% |
| 21 | $13.34 | 300 | $4K | 4.5% |
| 22 | $13.35 | 100 | $1K | 1.5% |
| 23 | $13.37 | 300 | $4K | 4.5% |
| 24 | $13.41 | 100 | $1K | 1.5% |
| 25 | $13.43 | 200 | $3K | 3.0% |
| 26 | $13.44 | 100 | $1K | 1.5% |
| 27 | $13.45 | 100 | $1K | 1.5% |
| 28 | $13.49 | 100 | $1K | 1.5% |
| Total | $13.19 avg | 6,800 | $90K | 100% |
| Filing → |
| MLNM | SELL | 2008-01-10 | $29K | — | Filing → |
| MLNM | SELL | 2008-01-10 | $122K | — | Filing → |
| MLNM | SELL | 2008-01-03 | $120K | — | Filing → |